GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Other Stockholders Equity

Longevity Biomedical (Longevity Biomedical) Other Stockholders Equity : $0.00 Mil (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Other Stockholders Equity?

Longevity Biomedical's Other Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil.


Longevity Biomedical Other Stockholders Equity Historical Data

The historical data trend for Longevity Biomedical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Other Stockholders Equity Chart

Longevity Biomedical Annual Data
Trend
Other Stockholders Equity

Longevity Biomedical Semi-Annual Data
Other Stockholders Equity

Longevity Biomedical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Longevity Biomedical Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines